Benitec(澳大利亞)

Benitec

澳大利亞Benitecwww.benitec.comBenitecCo.Ltd.是澳大利亞上市公司，世界上小核酸技術(shù)研發(fā)的先驅(qū)，擁有多項(xiàng)技術(shù)專利。許多醫(yī)藥界的巨頭，如默克，輝瑞等公司都購(gòu)買(mǎi)了他們的專利使用權(quán)。Benitec致力于利用小核酸基因沉默技術(shù)開(kāi)發(fā)治療人類重大疾病如艾滋病、癌癥及肝炎藥物的研究。其中與洛杉磯希望之城生物醫(yī)學(xué)和遺傳學(xué)中心共同開(kāi)發(fā)的治療艾滋病的小核酸干擾藥物已經(jīng)在美國(guó)FDA獲準(zhǔn)進(jìn) 入I期臨床試驗(yàn)階段。BenitecLtdisabiotechnologycompanylistedontheAustralianStockExchange(ASX:BLT).Foundedin1997tocommercialiseresearchfromQueensland'sDepartmentofPrimaryIndustries(DPI),BenitecisoneofthepioneersofRNAinterference(RNAi)technology,whichcanbeusedtopreciselydestroyRNAvirusesandsilencetheexpressionofdefectivegenes.Benitec'songoinggoalistogeneratevaluethroughthecommercialisationofddRNAiintheareaofhumantherapeutics.ThevisionisforBenitectobeaninternationallycompetitivecompanydedicatedtothedevelopmentoftreatmentsforserioushumandiseasesincludinginfectiousdiseases,neurologicaldisorders,cancerandautoimmunediseases,throughleadershipinRNAitechnologiesandst